Center for Scientific Review; Notice of Closed Meetings, 61647-61648 [2014-24381]
Download as PDF
61647
Federal Register / Vol. 79, No. 198 / Tuesday, October 14, 2014 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Forms
Principal Investigators .................
Administrative Supplements ...................
Year 1 Survey ........................................
Final Year Survey ..................................
Telephone Script for Non-Responders ..
Dated: October 6, 2014.
Karla Bailey,
NCI Project Clearance Liaison, National
Institutes of Health.
[FR Doc. 2014–24437 Filed 10–10–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
mstockstill on DSK4VPTVN1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:392:
New Computational Methods for
Understanding the Functional Role of DNA
Variants that are Associated with Mental
Disorder.
Date: October 29, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B,
MSC 7892, Bethesda, MD 20892, 301–408–
9655, gubina@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Vascular
Biology and Hematology AREA.
Date: November 6, 2014.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
16:59 Oct 10, 2014
Jkt 235001
24
52
52
16
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Larry Pinkus, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4132,
MSC 7802, Bethesda, MD 20892, (301) 435–
1214, pinkusl@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Child Psychopathology and
Developmental Disabilities.
Date: November 10–11, 2014.
Time: 8:00 a.m. to 11:59 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Mechanisms of Emotion, Stress and
Health.
Date: November 10–11, 2014.
Time: 8:00 a.m. to 11:59 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Mark Lindner, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, 301–435–
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Bacterial Biochemistry, Genetics,
and Evolution.
Date: November 10, 2014.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Barbara J. Thomas, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218,
MSC 7890, Bethesda, MD 20892, 301–435–
0603, bthomas@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
1
1
1
Average
burden per
response
(in hours)
1
1
1
3/60
Total annual
burden hours
24
52
52
1
Business: Non-HIV Anti-Infective
Therapeutics.
Date: November 12, 2014.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Alexandria Old
Town, 1456 Duke Street, Alexandria, VA
22314.
Contact Person: Kenneth M. Izumi, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge, Rm 3204, MSC 7808,
Bethesda, MD 20892, 301–496–6980,
izumikm@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; AREA
Application Review.
Date: November 12, 2014.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Liangbiao Zheng, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202,
MSC 7808, Bethesda, MD 20892, 301–996–
5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cell Biology.
Date: November 12, 2014.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Wallace Ip, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5128,
MSC 7840, Bethesda, MD 20892, 301–435–
1191, ipws@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Imaging and
Biomarkers for Early Cancer Detection:
PAR13–189.
Date: November 12, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Chiayeng Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Room 5213, MSC 7852, Bethesda, MD 20892,
301–435–2397, chiayeng.wang@nih.gov.
E:\FR\FM\14OCN1.SGM
14OCN1
61648
Federal Register / Vol. 79, No. 198 / Tuesday, October 14, 2014 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: October 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–24381 Filed 10–10–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–5752–N–85]
30-Day Notice of Proposed Information
Collection: Evaluation of the Rental
Assistance Demonstration Program,
Phase I
Office of the Chief Information
Officer, HUD.
ACTION: Notice.
AGENCY:
HUD has submitted the
proposed information collection
requirement described below to the
Office of Management and Budget
(OMB) for review, in accordance with
the Paperwork Reduction Act. The
purpose of this notice is to allow for an
additional 30 days of public comment.
DATES: Comments Due Date: November
13, 2014.
ADDRESSES: Interested persons are
invited to submit comments regarding
this proposal. Comments should refer to
the proposal by name and/or OMB
Control Number and should be sent to:
HUD Desk Officer, Office of
Management and Budget, New
Executive Office Building, Washington,
DC 20503; fax: 202–395–5806. Email:
OIRA_Submission@omb.eop.gov.
SUMMARY:
FOR FURTHER INFORMATION CONTACT:
Colette Pollard, Reports Management
Officer, QDAM, Department of Housing
and Urban Development, 451 7th Street
SW., Washington, DC 20410; email at
Colette Pollard@hud.gov or telephone
202–402–3400. Persons with hearing or
speech impairments may access this
number through TTY by calling the tollfree Federal Relay Service at (800) 877–
8339. This is not a toll-free number.
Copies of available documents
submitted to OMB may be obtained
from Ms. Pollard.
SUPPLEMENTARY INFORMATION: This
notice informs the public that HUD has
submitted to OMB a request for
approval of the information collection
described in Section A.
The Federal Register notice that
solicited public comment on the
information collection for a period of 60
days was published on June 28, 2014.
A. Overview of Information Collection
Title of Information Collection:
Evaluation of the Rental Assistance
Demonstration Program, Phase I.
OMB Approval Number: 2528—New.
Type of Request: New collection.
Description of the need for the
information and proposed use: The
Rental Assistance Demonstration
program (RAD) was established in 2012
to stem the loss of public housing units
and other subsidized housing arising
from a backlog of capital needs. The
program helps to convert at-risk public
housing properties to two different
forms of project-based Section 8
Housing Assistance Payments (HAP)
contracts—either project-based voucher
(PBV) or project-based rental assistance
(PBRA)—giving public housing
authorities (PHAs) more flexibility to
access private and public funding
sources, easing their reliance on
unpredictable appropriations. The RAD
Number of
respondents
Form
Respondent sample
Physical and Financial Conditions
Survey.
PHAs (n = 72 PHAs; 24 PHAs implementing RAD, 48 PHAs not implementing RAD.
PHAs, stakeholder, implementation
consultants, project managers (n
= 100).
Tenants of RAD PHAs (n = 400) .....
...........................................................
mstockstill on DSK4VPTVN1PROD with NOTICES
Implementation Survey .....................
Resident Intake Study Correspondence and Intake Form.
Total Burden Hours ...................
VerDate Sep<11>2014
16:59 Oct 10, 2014
Jkt 235001
PO 00000
Frm 00053
Fmt 4703
authorizing statute requires HUD to
assess the impact of the program on: (1)
The preservation and improvement of
former public housing units, (2) the
amount of private capital leveraged as a
result of such conversions, and (3) the
effect of conversion on residents.
The evaluation is designed to examine
the resources available to improve the
physical conditions of a public housing
property, what new opportunities RAD
creates for PHAs to improve public
housing physical conditions, and how it
helps PHAs preserve those units over
the long term. To examine whether the
stated HUD and PHA objectives are
achieved, HUD will be collecting
quantitative and qualitative data from
primary and secondary sources and
analyzing data related to the following:
(1) The physical and financial
conditions of 24 RAD properties
selected for the study and 48 non-RAD
properties selected for comparison; (2)
the implementation of the program,
including the capital needs and amount
of private funding leveraged; and (3) the
experience with, and effect on,
residents.
At this time, funding is available to
fund only the first two components of
the evaluation, thus, this request for
OMB clearance only covers the ‘‘first
phase’’ of the evaluation—(1) an
assessment of the baseline conditions of
RAD properties chosen for study and
the baseline conditions of the
comparison non-RAD properties, and (2)
an assessment of the initial RAD
financing, and the implementation
phase of the RAD program. The request
also includes a tracking form for the
resident study that will be completed as
a second phase of the evaluation, should
funding be made available.
Respondents: PHAs and PHA tenants.
Average
time to
complete
(minimum,
maximum)
in minutes
Total
burden
(hours)
Frequency
72
60 (50–70)
1
72
100
60 (50–70)
1
100
400
10 (8–12)
1
67
........................
........................
........................
239
Sfmt 4703
E:\FR\FM\14OCN1.SGM
14OCN1
Agencies
[Federal Register Volume 79, Number 198 (Tuesday, October 14, 2014)]
[Notices]
[Pages 61647-61648]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-24381]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR:392: New Computational Methods for Understanding the
Functional Role of DNA Variants that are Associated with Mental
Disorder.
Date: October 29, 2014.
Time: 12:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Alexander Gubin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6046B, MSC 7892, Bethesda, MD
20892, 301-408-9655, gubina@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Vascular Biology and Hematology AREA.
Date: November 6, 2014.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435-
1214, pinkusl@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Child Psychopathology and Developmental
Disabilities.
Date: November 10-11, 2014.
Time: 8:00 a.m. to 11:59 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark Lindner, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301-435-
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Mechanisms of Emotion, Stress and Health.
Date: November 10-11, 2014.
Time: 8:00 a.m. to 11:59 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Mark Lindner, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD 20892, 301-435-
0913, mark.lindner@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Bacterial Biochemistry, Genetics, and
Evolution.
Date: November 10, 2014.
Time: 2:30 p.m. to 4:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Barbara J. Thomas, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2218, MSC 7890, Bethesda, MD
20892, 301-435-0603, bthomas@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Non-HIV Anti-Infective Therapeutics.
Date: November 12, 2014.
Time: 8:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Alexandria Old Town, 1456 Duke Street,
Alexandria, VA 22314.
Contact Person: Kenneth M. Izumi, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge, Rm 3204, MSC 7808, Bethesda, MD 20892, 301-
496-6980, izumikm@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; AREA Application Review.
Date: November 12, 2014.
Time: 9:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Liangbiao Zheng, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3202, MSC 7808, Bethesda, MD
20892, 301-996-5819, zhengli@csr.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cell Biology.
Date: November 12, 2014.
Time: 10:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wallace Ip, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5128, MSC 7840, Bethesda, MD 20892, 301-435-
1191, ipws@mail.nih.gov.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Imaging and Biomarkers for Early Cancer Detection: PAR13-189.
Date: November 12, 2014.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Chiayeng Wang, Ph.D., Scientific Review Officer,
Center for Scientific Review, 6701 Rockledge Drive, Room 5213, MSC
7852, Bethesda, MD 20892, 301-435-2397, chiayeng.wang@nih.gov.
[[Page 61648]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: October 7, 2014.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-24381 Filed 10-10-14; 8:45 am]
BILLING CODE 4140-01-P